Concord Biotech - News

NSE: CONCORDBIO | BSE: 543960

₹1,359.70

₹-9.10 (-0.66%)

As on 07-Oct-2026IST

Market cap

₹14,199 Cr

Revenue (TTM)

₹1,108 Cr

P/E Ratio

51.6

P/B Ratio

6.8

Div. Yield

0.6 %

Quarterly Updates

2026

2025

2024

2023

Annual Reports

Annual Reports

2026

Annual Reports

2025

Annual Reports

2024

Announcements

View Announcements

Recent

Important

Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018

07-Oct-2026

Closure of Trading Window

28-Sep-2026

Announcement under Regulation 30 (LODR)-Newspaper Publication

25-Sep-2026

Shareholder Meeting / Postal Ballot-Notice of Postal Ballot

24-Sep-2026

Board Meeting Outcome for The Board Of Director At Its Meeting Held Today I.E. Wednesday September 23 2026 Has Inter-Alia Considered And Approved Issuance Of Bonus Shares & Increase In The Authorised Share Capital Of The Company.

23-Sep-2026

Board Meeting Intimation for Meeting To Be Held On Wednesday September 23 2026 Pursuant To Regulation 29 Of The SEBI (LODR) Regulations 2015 Inter-Alia To Consider The Proposal For Declaration Of Bonus Equity Shares To The Existing Equity Shareholders Of The Company

19-Sep-2026

Intimation Of Outcome Of U.S. Food And Drug Administration (USFDA) Inspection At Unit II - Valthera Formulation Facility Of The Company

18-Sep-2026

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

17-Sep-2026

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

21-Aug-2026

Announcement under Regulation 30 (LODR)-Earnings Call Transcript

07-Aug-2026